NEWS
What Is a Fair Reimbursement Price for Orphan Drugs in Germany?
In the current draft of the Act on the Stabilisation of Finances for the Statutory Health Insurance in Germany, the threshold for...
Revision of the EU Orphan Legislation – Implications for the German Benefit Assessment RAPS Euro Convergence on 10-12 May 2022 in Amsterdam, Netherlands
Back on stage! This year’s RAPS Euro Convergence in Amsterdam gave Dr. Meriem Bouslouk-Marx the floor to outline the...
Showing my stripes for this year’s Rare Disease Day
Oral and maxillofacial surgery was one major discipline during my last years of dental medicine at the Friedrich Schiller...
How can Germany pay for innovative therapies in the future? Fair access to medicines in the future – A challenge not only in times of corona. 11 March 2021, online event
Advanced Therapy Medicinal Products (ATMPs) especially those for the treatment of rare diseases are innovative but also very...
A global fund to tackle antimicrobial resistance (AMR) New initiative takes on the antibiotic innovation challenge: Global launch event on 9 July 2020, online event
In July 2020, the International Federation of Pharmaceutical Manufacturers & Associations IFPMA, the European Federation of...